Pathstone Holdings’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$630K Buy
46,515
+13,203
+40% +$158K ﹤0.01% 1751
2026
Q1
$200K Buy
33,312
+9,128
+38% +$68.7K ﹤0.01% 2110
2025
Q4
$173K Sell
24,184
-19,555
-45% -$154K ﹤0.01% 2124
2025
Q3
$467K Buy
43,739
+23,621
+117% +$232K ﹤0.01% 1804
2025
Q2
$194K Sell
20,118
-33,488
-62% -$345K ﹤0.01% 2064
2025
Q1
$798K Buy
53,606
+19,302
+56% +$297K ﹤0.01% 1495
2024
Q4
$512K Sell
34,304
-3,254
-9% -$53K ﹤0.01% 1708
2024
Q3
$719K Sell
37,558
-1,234
-3% -$25.6K ﹤0.01% 1545
2024
Q2
$803K Buy
38,792
+1,041
+3% +$20.7K ﹤0.01% 1441
2024
Q1
$710K Buy
37,751
+6,023
+19% +$103K ﹤0.01% 1507
2023
Q4
$459K Buy
+31,728
New +$432K ﹤0.01% 1563

Other funds holding OGN

Pathstone Holdings's OGN Position: Q2 2026 in Review

Pathstone Holdings increased its Organon & Co (OGN) stake by 40% in Q2 2026, buying an estimated $158K and bringing the position to 46,515 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Pathstone Holdings first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $803K in Q2 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Pathstone Holdings held 46,515 shares of Organon & Co worth $630K as of Q2 2026.
  • Pathstone Holdings bought 13,203 Organon & Co shares in Q2 2026, an estimated $158K.
  • Organon & Co made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1751 holding.
  • Pathstone Holdings first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Organon & Co position peaked at $803K in Q2 2024.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.